Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
April 24, 2026 1:00 PM EDT
Truist reiterated its Buy rating on one managed healthcare stock in a note this week following what the firm called a solid first-quarter earnings report.
Analyst David MacDonald said Health Benefits drove the bulk of Elevance Health's (NYSE: ELV) beat, with better-than-expected performance across Medicaid, Medicare and Commercial segments. He maintained $375 price target... More
April 24, 2026 1:00 PM EDT
Truist reiterated its Buy rating on one managed healthcare stock in a note this week following what the firm called a solid first-quarter earnings report.
Analyst David MacDonald said Health Benefits drove the bulk of Elevance Health's (NYSE: ELV) beat, with better-than-expected performance across Medicaid, Medicare and Commercial segments. He maintained $375 price target... More
April 22, 2026 6:01 AM EDT
Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $12.58, $1.74 better than the analyst estimate of $10.84. Revenue for the quarter came in at $49.5 billion versus the consensus estimate of $48.2 billion.
GUIDANCE:
Elevance Health Inc. sees FY2026 EPS of $26.75, versus the consensus of... More
